Construction of a nomogram for predicting pathological upgrading after LEEP in patients with preoperative biopsy-confirmed CIN1/2 based on colposcopic morphological features: A retrospective cohort study

Cervical Intraepithelial Neoplasia (CIN) grade 1/2 diagnosed by colposcopy-directed biopsy may underestimate the final lesion grade found on excision. In patients who proceed to Loop Electrosurgical Excision Procedure (LEEP), postoperative pathology may show histopathological upgrading relative to the preoperative biopsy. Although HPV testing and ThinPrep Cytology Test (TCT) are standard screening tools, their differential value in this LEEP-selected CIN1/2 population remains unclear. This study aimed to identify factors associated with pathological upgrading after LEEP and to construct an internally validated nomogram based on colposcopic morphological features. We retrospectively analyzed 122 patients who underwent LEEP for clinical indications between 2020 and 2025 with preoperative biopsy-confirmed CIN1/2. Pathological upgrading was defined as biopsy CIN1 with LEEP pathology ≥ CIN2, or biopsy CIN2 with LEEP pathology ≥ CIN3 (invasive carcinoma included). These 2 transitions were prespecified and are clinically distinct; event counts were, therefore, also reported by baseline biopsy grade. Multivariable logistic regression was used to develop a nomogram. Discrimination and calibration were assessed with ROC analysis and bootstrap internal validation; clinical utility was explored with decision curve analysis (DCA). Pathological upgrading occurred in 46/122 (37.7%) patients in this LEEP-selected cohort, including 4/15 (26.7%) with baseline CIN1 and 42/107 (39.3%) with baseline CIN2. In the multivariable model, Reid Colposcopic Index (OR = 1.41, P = .013) and number of involved quadrants (OR = 1.93, P = .018) were significantly associated with upgrading, whereas menopausal status (OR = 2.83, P = .059) and biopsy count (OR = 0.70, P = .068) did not reach conventional significance but were retained as candidate predictors. HPV genotype category and TCT were not significantly associated with upgrading. The nomogram showed apparent AUC 0.801 (95% CI 0.719-0.883) on internal evaluation; calibration and DCA supported exploratory clinical utility within this surgical cohort. In women with biopsy-confirmed CIN1/2 who already had indications for LEEP, colposcopic morphological features (Reid score and lesion extent) were more informative than HPV/TCT for predicting histopathological upgrading after excision. The nomogram may assist risk stratification within this selected surgical population. An ROC-derived probability threshold of 43% is presented only as an exploratory cut-point requiring external validation and should not yet be used as a standalone rule to choose observation vs LEEP in unselected CIN1/2 patients.

Authors

Institutions

Publication Details

Journal
Medicine
Published
2026-11-13
DOI
https://doi.org/10.1097/md.0000000000051590
Primary Topic
Cervical Cancer and HPV Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Construction of a nomogram for predicting pathological upgrading after LEEP in patients with preoperative biopsy-confirmed CIN1/2 based on colposcopic morphological features: A retrospective cohort study

刘晓龙, Ying Xie, Ling Chen, Dan Liu
2 links
Medicine
Cervical Cancer and HPV Research
article

Construction of a nomogram for predicting pathological upgrading after LEEP in patients with preoperative biopsy-confirmed CIN1/2 based on colposcopic morphological features: A retrospective cohort study

刘晓龙, Ying Xie, Ling Chen, Dan Liu
article en

Abstract

Cervical Intraepithelial Neoplasia (CIN) grade 1/2 diagnosed by colposcopy-directed biopsy may underestimate the final lesion grade found on excision. In patients who proceed to Loop Electrosurgical Excision Procedure (LEEP), postoperative pathology may show histopathological upgrading relative to the preoperative biopsy. Although HPV testing and ThinPrep Cytology Test (TCT) are standard screening tools, their differential value in this LEEP-selected CIN1/2 population remains unclear. This study aimed to identify factors associated with pathological upgrading after LEEP and to construct an internally validated nomogram based on colposcopic morphological features. We retrospectively analyzed 122 patients who underwent LEEP for clinical indications between 2020 and 2025 with preoperative biopsy-confirmed CIN1/2. Pathological upgrading was defined as biopsy CIN1 with LEEP pathology ≥ CIN2, or biopsy CIN2 with LEEP pathology ≥ CIN3 (invasive carcinoma included). These 2 transitions were prespecified and are clinically distinct; event counts were, therefore, also reported by baseline biopsy grade. Multivariable logistic regression was used to develop a nomogram. Discrimination and calibration were assessed with ROC analysis and bootstrap internal validation; clinical utility was explored with decision curve analysis (DCA). Pathological upgrading occurred in 46/122 (37.7%) patients in this LEEP-selected cohort, including 4/15 (26.7%) with baseline CIN1 and 42/107 (39.3%) with baseline CIN2. In the multivariable model, Reid Colposcopic Index (OR = 1.41, P = .013) and number of involved quadrants (OR = 1.93, P = .018) were significantly associated with upgrading, whereas menopausal status (OR = 2.83, P = .059) and biopsy count (OR = 0.70, P = .068) did not reach conventional significance but were retained as candidate predictors. HPV genotype category and TCT were not significantly associated with upgrading. The nomogram showed apparent AUC 0.801 (95% CI 0.719-0.883) on internal evaluation; calibration and DCA supported exploratory clinical utility within this surgical cohort. In women with biopsy-confirmed CIN1/2 who already had indications for LEEP, colposcopic morphological features (Reid score and lesion extent) were more informative than HPV/TCT for predicting histopathological upgrading after excision. The nomogram may assist risk stratification within this selected surgical population. An ROC-derived probability threshold of 43% is presented only as an exploratory cut-point requiring external validation and should not yet be used as a standalone rule to choose observation vs LEEP in unselected CIN1/2 patients.

MedicineVol. 105(46)
Jinan University (CN)
Good health and well-being
Cervical Cancer and HPV Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon